WHO ICTRP trial

Can good blood glucose control be reached with a decision support system in…

EUCTR2014-004418-27-AT · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2014-004418-27-AT
Public title Can good blood glucose control be reached with a decision support system in patients who underwent stemm cell transplantation
Scientific title Standardized tight blood glucose management versus usual glycaemic control in patients undergoing allogeneic stem cell transplantation – a pilot trial - The GISMO Trial
Primary sponsor Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. f. Endokrinologie und Stoffwechsel
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes
Countries Austria
Conditions Hyperglycaemic patients;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
Interventions Trade Name: Novorapid Pharmaceutical Form: Solution for injection in pre-filled pen INN or Proposed INN: INSULIN ASPART CAS Number: 116094-23-6 Concentration unit: IU international unit(s) Concentration type: equal Concentration number…
Registration date Mar 18, 2015
Target size 10
Secondary IDs HS02/2014
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations